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Polyhydramnios among women in a
cluster-randomized trial of ultrasound
during prenatal care within five low and
low-middle income countries: a secondary
analysis of the first look study
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Waseem Mirza8, Nancy Krebs9, Michael Hambidge9, Waldemar Carlo10, Elwyn Chomba11, Menachem Miodovnik12,
Marion Koso-Thomas12, Edward A. Liechty13, Fabian Esamai14, Jonathan Swanson15, David Swanson16,
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Abstract
Background: In many low and low-middle income countries, the incidence of polyhydramnios is unknown, in part
because ultrasound technology is not routinely used. Our objective was to report the incidence of polyhydramnios
in five low and low-middle income countries, to determine maternal characteristics associated with
polyhydramnios, and report pregnancy and neonatal outcomes.
Methods: We performed a secondary analysis of the First Look Study, a multi-national, cluster-randomized trial of
ultrasound during prenatal care. We evaluated all women enrolled from Guatemala, Pakistan, Zambia, Kenya and
the Democratic Republic of Congo (DRC) who received an examination by prenatal ultrasound. We used pairwise
site comparisons with Tukey-Kramer adjustment and multivariable logistic models with general estimating
equations to control for cluster-level effects. The diagnosis of polyhydramnios was confrimed by an U.S. based
radiologist in a majority of cases (62%).
Results: We identified 305/18,640 (1.6%) cases of polyhydramnios. 229 (75%) cases were from the DRC, with an
incidence of 10%. A higher percentage of women with polyhydramnios experienced obstructed labor (7% vs 4%)
and fetal malposition (4% vs 2%). Neonatal death was more common when polyhydramnios was present
(OR 2.43; CI 1.15, 5.13).
Conclusions: Polyhydramnios occured in these low and low-middle income countries at a rate similar to high-
income contries except in the DRC where the incidence was 10%. Polyhydramnios was associated with obstructed
labor, fetal malposition, and neonatal death.
Trial registration: NCT01990625, November 21, 2013.
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Background
Polyhydramnios, or an excessive accumulation of amni-
otic fluid, affects less than 2% of pregnancies in high-in-
come countries [1, 2]. Polyhydramnios can be associated
with adverse outcomes such as perinatal mortality, pre-
maturity, shoulder dystocia, and respiratory distress
syndrome, and is therefore an important health concern
[3–5]. Polyhydramnios can result from maternal condi-
tions such as poorly controlled diabetes, infections and
medication exposure [4]. Fetal conditions that affect the
fetus’s ability to swallow or obstructive gastrointestinal
pathologies can also result in polyhydramnios [4].
In many low and low-middle income countries
(LMICs), the incidence of polyhydramnios is unknown.
The use of ultrasound during prenatal care is limited in
many LMICs due to the high cost of purchasing and
maintaining ultrasound equipment, and lack of trained
providers to perform and interpret these studies. As a
result, certain pregnancy-related conditions that are usu-
ally detected by ultrasound go undiagnosed, including
polyhydramnios, oligohydramnios and fetal growth
abnormalities [6]. These conditions can lead to adverse
perinatal events, and therefore should be recognized in
order to improve maternal and neonatal outcomes.
Maternal and neonatal outcomes associated with polyhy-
dramnios may be worse in LMICs due to limitations in
emergent obstetric care and intensive care for infants
born prematurely. Understanding the epidemiology of
polyhydramnios in LMICs might lead to strategies for
reducing perinatal and peripartum morbidity and
mortality.
Pregnant women in LMICs may have different under-
lying risk factors for polyhydramnios when compared to
women in high-income countries. Women in LMICs
have different nutritional status, infection exposures,
prevalence of diabetes and incidence of fetal anomalies
than women in high-income countries [2, 7–10]. These
differences in exposure might alter the prevalence of
polyhydramnios in these regions. These maternal
characteristics might also contribute to worse perinatal
outcomes.
In this paper, we report the incidence of polyhydram-
nios among women in five LMICs. We also report ma-
ternal characteristics associated with polyhydramnios
and the pregnancy and neonatal outcomes among those
affected.
Methods
We evaluated all women enrolled in the First Look
Study who received one or more prenatal ultrasounds.
The details of the First Look Study have been described
elsewhere, but briefly, this was a multi-country study
conducted from July 2014 to May 2016 to determine if
the use of ultrasound technology during prenatal care in
LMICs improved maternal mortality, maternal near-miss
mortality, stillbirth and neonatal mortality [6, 11]. The
First Look Study was a cluster randomized trial in rural
areas within five LMICs: Guatemala, Democratic Repub-
lic of Congo (DRC), Zambia, Pakistan and Kenya.
Women living in the intervention clusters were asked to
receive two ultrasound examinations at antenatal care
visits, the first when pregnancy was identified, ideally be-
tween 16 and 22 weeks, and the second at 32–36 weeks
of gestation. Many of the first ultrasounds were
performed after the ideal gestational window, but most
of the second ultrasounds were preformed within the
ideal window. The first ultrasound was used to estimate
gestational age, fetal number and position, amniotic fluid
abnormalities, cervical length and major congenital
anomalies. The second ultrasound evaluated placental
location, fetal growth, fetal position, amniotic fluid
abnormalities, and major congenital anomalies.
Medical officers, nurses, midwives, and radiographers
with no prior ultrasound experience were trained in the
use of obstetric ultrasound during a two-week training
period under the supervision of a radiologist (RN) based
at the University of Washington, Seattle, WA, USA,
using the curriculum based from the Basic Obstetric
Ultrasound Training Instructor Guide and Basic Obstet-
ric Ultrasound Participant Manual, developed at the
University of Washington [12]. All trainees were evalu-
ated using pre- and post written and practical scanning
tests. Central trainers evaluated the skills of all trainess
and certified those who successfully completed the
course. All sites successfully completed a three-month
pilot period to evaluate the sonographers’ ability and the
integration of the study procedures into the context of
the local health care system before inclusion in the
study. Throughout the trial, quality asurance (QA) pro-
cedures were in place to maintain appropriate accuracy
of ultrasound diagnosis. These QA procedures included
uploading of ultrasound images to a website for periodic
review of field ultrasound, and central trainers working
on site with study staff to periodically evaluate the qual-
ity of images produced by community ultrasonogra-
phers. Refresher training sessions lasting 2–3 days were
held approximately six months after the initial two week
ultrasound training.
We defined polyhydramnios using the following criteria:
a maximum vertical pocket (MVP) of 8 cm or greater and
amniotic fluid index (AFI) of 24 cm or greater. MVP was
used for twins or for fetuses less than 24 weeks gestational
age (GA), and AFI for GA of 24 weeks or greater. We con-
sidered a woman to have polyhydramnios if polyhydram-
nios was identified on any of the ultrasounds during her
pregnancy. A single reviewer at the University of
Washington (RN) reviewed a sample of 62% of cases
polyhydramnios to ensure accuracy of diagnosis.
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In this secondary analysis, we included all women
from the First Look study who completed the study and
had delivery outcomes recorded. We excluded maternal
or fetal deaths that occurred prior to 20 weeks. Because
the prevalence of polyhydramnios was higher in the
DRC than the other sites, we first determined if the inci-
dence of polyhydramnios in the DRC was statistically
different from each of the other sites, and then verified
that the incidence at the other sites was not statistically
different from each other. We obtained mean differences
from a logistic model evaluating women with polyhy-
dramnios, using general estimating equations (GEE) to
control for cluster level effects within countries with site
included as an explanatory variable. We obtained
means from the model for all pairwise site compari-
sons and p-values with a Tukey-Kramer adjustment
for multiple comparisons. Because the DRC was sig-
nificantly different from all other sites with adjusted
p-values < 0.001 for all comparisons, but we found
minimal difference among other sites, we adjusted all
subsequent models for the DRC compared with all
other sites.
To determine the maternal characteristics associated
with polyhydramnios a priori, we built a regression
model. To evaluate the maternal characteristics, we built
individual logistic models for each characteristic and the
finding of polyhydramnios with GEE to control for clus-
ter level effects, and DRC/other site and the characteris-
tic included as explanatory variables. We then built a
multivariable logistic model for polyhydramnios and all
maternal characteristics that had an association with
polyhydramnios (p < 0.10) as explanatory models,
using GEE extensions. We excluded maternal weight
from this model due to 16% missing values from
Kenya and measurement variability across multiple
different time points in gestation across sites. The
final model included the following maternal character-
istics: maternal age, parity, and previous live birth.
Due to small number of cases and to avoid multiple
testing, we did not analyze maternal characterisitics
in each of the five LMICs separately.
We then determined the risk of selected outcomes
adjusting for polyhydramnios, DRC/other site and the
maternal characteristics evaluated in the previous multi-
variable model. For binomial outcomes, we created a
multivariable logistic model with GEE extensions to con-
trol for cluster level effects, DRC/other site, maternal
characteristics and polyhydramnios. We report the odds
ratio and 95% confidence intervals. For continuous out-
comes, we created a regression model with GEE exten-
sions to control for cluster level effects, DRC/other site,
maternal characteristics and polyhydramnios. For these
models, we report the estimates and 95% confidence
intervals. We considered p < 0.05 significant, beta 0.80.
All analyses were performed at the Data Coordinating
Center at RTI International (Durham, NC) using SAS,
Inc. version 9.4.
At each site, institutional review boards or ethics com-
mittees approved the primary study. All women pro-
vided written informed consent before the start of the
study. A data monitoring committee, appointed by the
NICHD oversaw and reviewed the study annually. This
study was supported by grants from the Bill & Melinda
Gates Foundation, Eunice Kennedy Shriver National In-
stitute of Child Health and Human Development, and
by a grant from GE Healthcare.
Results
We identified 305 (1.6%) cases of polyhydramnios
among 18,640 women. The incidence of polyhydramnios
ranged from 0.3% in Guatemala to 10% in DRC (Table 1).
Of the women identified with polyhydramnios, 229
(75%) were from the DRC. Compared to women with-
out polyhydramnios, women with polyhydramnios
were more often older than 35 years (10% vs 7%, p <
0.001), had more than 2 previous live births (71% vs
52%, p < 0.001), had a previous live birth (98% vs
94%, < 0.001) and lower mean maternal weight (55.8
kg vs 56.5 kg, p = 0.005), Table 2. These trends
persisted when the DRC data were evaluated separ-
ately from the other sites, with the exception of mean
maternal weight. In the DRC, the mean maternal
weight was higher among the women with polyhy-
dramnios compared to the women without polyhy-
dramnios (54.5 kg vs 53.5 kg). In a multivariable
model evaluating maternal characteristics and polyhy-
dramnios, evaluating DRC site vs. other sites, age,
parity, previous live birth, and using GEE to control
for cluster level effects, the DRC had an odds ratio of
22.6 (14.87, 34.35), (Table 3).
We observed a higher percentage of women who expe-
rienced obstructed labor (7% vs 4%) and fetal malposi-
tion (4% vs 2%) among the women with polyhydramnios
(Table 4). These trends persisted when DRC was evalu-
ated separately from the other sites. The number of
women who delivered by Cesarean section (C-section)
Table 1 Incidence of Polyhydramnios by Site
Overall DRC Kenya Zambia Guatemala Pakistan
N 18,640 2,291 3,380 4,408 6,157 2,404
Incidence of Polyhydramnios, n (%) 305 (1.6) 229 (10.0) 15 (0.4) 30 (0.7) 21 (0.3) 10 (0.4)
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was lower among women with polyhydramnios in the
overall analysis (6 vs 12%), but when DRC data were
evaluated separately from the other sites, a larger por-
tion of women in the DRC with polyhydramnios were
delivered by C-section compared to women without
polyhydramnios (3 vs 1%). The percentage of women
who were delivered by C-section was equivalent in the
two groups across other sites (13%).
In a multivariable regression model, adjusting for age,
parity, previous live birth and controlling for cluster
level effects, the odds ratio for neonatal death in preg-
nancies that were complicated by polyhydramnios was
2.43 (1.15, 5.13), (Table 4). Neonatal mortality rates were
higher in the DRC when polyhydramnios was present
(23/1,000 vs 18/1,000). The odds of stillbirth given
polyhdramnios was 1.29 (0.78, 2.12). The incidence of
preterm birth was not different among pregnancies com-
plicated by polyhydramnios compared to those without
polyhydramnios (11% vs 13%), and the odds ratio was
not significant when adjusted for the previous variables.
Polyhydramnios was associated with a higher mean
birthweight at delivery (3082 g vs 2979 g), although this
was not significant in the final model. In the DRC,
among pregnancies affected by polyhydramnios, a
lower proportion of infants were born with low birth
weight (7 vs 11%), (Table 4).
Discussion
The First Look Study evaluated the effect of introducing
ultrasound technology in regions of LMICs where ultra-
sound had not been a component of prenatal care [11].
The objective of the First Look Study was to determine
if introducing prenatal ultrasound to resource-limited
areas would reduce maternal mortality, maternal near-
miss mortality, stillbirth and neonatal mortality. While
Table 2 Maternal Characteristics by Polyhydramnios
Overall DRC Other Sites
With
Polyhydramnios
No
Polyhydramnios
P-value* With
Polyhydramnios
No
Polyhydramnios
With
Polyhydramnios
No
Polyhydramnios
Maternal age (years) 305 18,323 0.0009 229 2,062 76 16,261
< 20 36 (12) 3,351 (18) 27 (12) 443 (22) 9 (12) 2,908 (18)
20–35 238 (78) 13,618 (74) 182 (80) 1,482 (72) 56 (74) 12,136 (75)
> 35 31 (10) 1,354 (7) 20 (9) 137 (7) 11 (15) 1,217 (8)
Maternal education, n 305 18,327 0.4834 229 2,062 76 16,265
No formal schooling 93 (31) 3,850 (21) 77 (34) 654 (32) 16 (21) 3,196 (20)
Primary 127 (42) 5,488 (30) 103 (45) 957 (46) 24 (32) 4,531 (28)
Secondary 82 (27) 8,232 (45) 49 (21) 442 (21) 33 (43) 7,790 (48)
University 3 (1) 757 (4) 0 (0) 9 (0) 3 (4) 748 (5)
Parity, n 304 18,055 < 0.0001 229 2,062 75 15,993
0 41 (14) 4,576 (25) 24 (11) 434 (21) 17 (23) 4,142 (26)
1 48 (16) 4,089 (23) 41 (18) 389 (19) 7 (9) 3,700 (23)
2+ 215 (71) 9,390 (52) 164 (72) 1,239 (60) 51 (68) 8,151 (51)
Previous live birth, n (%) 258 (98) 12,652 (94) 0.0006 202 (99) 1,582 (97) 56 (97) 11,070 (93)
Maternal height, cm, Mean (std) 157.1 (7.7) 153.5 (8.1) 0.2147 157.7 (7.3) 157.7 (6.5) 154.9 (8.8) 152.9 (8.1)
Maternal weight, kg, Mean (std) 55.8 (9.8) 56.5 (10.2) 0.0045 54.4 (7.5) 53.5 (6.9) 60.0 (14.1) 56.9 (10.4)
*P-value from a logistic regression model for polyhydramnios, adjusting for DRC/Other and maternal characteristic with general estimating equations
Table 3 Association of maternal characteristics and
polyhydramnios
Odds Ratio (95% CI)* P-value*
Country < 0.0001
DRC 22.60 (14.87, 34.35) < 0.0001
Other Reference
Maternal age (years) 0.0820
< 20 0.72 (0.52, 0.99) 0.0438
20–35 Reference
> 35 1.29 (0.94, 1.76) 0.1107
Parity 0.0596
0 1.76 (0.77, 4.02) 0.1803
1 Reference
2+ 1.44 (1.07, 1.93) 0.0176
Previous live birth
Yes 2.00 (0.91, 4.41) 0.0850
No or Primiparous Reference
*From a multivariable logistic regression model for polyhydramnios adjusting
for DRC/Other, age, parity and previous live birth with general estimating
equations to control for cluster level effects
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the First Look Study did not see a difference in the pri-
mary outcome by using prenatal ultrasound, a higher
than expected incidence of polyhydramnios was identi-
fied. We report the incidence of polyhydramnios in these
regions, where data on polyhydramnios is limited. The
incidence of polyhydramnios in the DRC was much
higher than the incidence reported in high-income
countries, and higher than the incidence in the other
LMICs included in the First Look Study: Guatemala,
Pakistan, Kenya and Zambia. Women with polyhy-
dramnios were older, had more than 2 children, and
lower weight. Across all countries, polyhydramnios
was associated with adverse pregnancy and birth out-
comes such as obstructed labor, fetal malpresentation
and neonatal death.
Our study had several key strengths. This is the first
study to evaluate prenatal ultrasound in relation to
polyhydramnios in these regions of the world. To ensure
accurate diagnosis of ultrasound findings, we conducted
rigorous training, a pilot trial to ensure accurate results
and frequent quality assurance checks throughout the
study. Additionally, our ultrasound findings were verified
by an independent US-based radiologist. We evaluated all
patients in the First Look Study, which enrolled pregnant
women within the study communities. This method of
data collection permitted population-level conclusions for
the communities studied; therefore, our data are rep-
resentative of these communities. Our study does
have some practical limitations. Although this study is
representative of the study communities, the results
might not be representative of the country as a
whole. Furthermore, because our study was a second-
ary analysis of the First Look Study, we were limited
by the data that were collected for the primary study.
Table 4 Delivery Complications and Fetal/Neonatal Outcomes by Polyhydramnios
Overall DRC Other
With
Polyhydramnios
N = 305
No
Polyhydramnios
N = 18,327
Odds Ratiob/
Estimatec
(95% CI)
With
Polyhydramnios
N = 229
No
Polyhydramnios
N = 2062
With
Polyhydramnios
N = 76
No
Polyhydramnios
N = 16,265
Delivery complications
Obstructed labor, n (%) 20 (7) 773 (4) 12 (5) 43 (2) 8 (11) 730 (5)
Hemorrhage, n (%) 6 (2) 360 (2) 1 (0) 20 (1) 5 (7) 340 (2)
Hypertensive disorder,
n (%)
6 (2) 366 (2) 0 (0) 0 (0) 6 (8) 366 (2)
Fetal malposition, n (%) 12 (4) 352 (2) 7 (3) 13 (1) 5 (7) 339 (2)
C-section delivery, n (%) 17 (6) 2,154 (12) 7 (3) 28 (1) 10 (13) 2,126 (13)
Maternal death < 42
days, n (rate/100,000
deliveries)
0 (0) 23 (126) 0 (0) 3 (146) 0 (0) 20 (123)
Maternal sepsis, n (%) 5 (2) 281 (2) 2 (1) 27 (1) 3 (4) 254 (2)
Fetal/Neonatal outcomesa
Male, n (%) 173 (57) 9,314 (51) 137 (60) 1,068 (52) 36 (47) 8,246 (51)
Low birth weight, n (%) 23 (8) 2,288 (13) 15 (7) 226 (11) 8 (11) 2,062 (13)
GA at delivery, Mean
(std)
39.0 (2.9) 38.6 (3) 39.1 (3) 38.7 (13) 38.8 (3.4) 38.5 (5)
Multiple gestation, n (%) 1 (0) 205 (1) 0 (0) 42 (2) 1 (1) 163 (1)
Congenital anomaly,
n (%)
0 (0) 32 (0) 0 (0) 0 (0) 0 (0) 32 (0)
Stillbirth, n (rate/1,000) 13 (43) 451 (25) 1.29 (0.78, 2.12) 10 (44) 77 (37) 3 (40) 374 (23)
Birth weight, g, Mean
(std)
3082 (551) 2979 (498) 79.2 (31.1, 127.2) 3102 (528) 2965 (533) 3023 (615) 2981 (494)
Preterm Birth, n (%) 33 (11) 2,359 (13) 0.89 (0.54, 1.46) 22 (10) 262 (13) 11 (16) 2,097 (13)
Neonatal death < 28
days, n (rate/1,000)
12 (41) 379 (21) 2.43 (1.15, 5.13) 5 (23) 36 (18) 7 (97) 343 (22)
aFetal/Neonatal outcomes are calculated at the maternal level if at least one fetus/neonate has the outcome
bOdds Ratio from a multivariable logistic regression model adjusting for at least one polyhydramnios finding, DRC/Other, Age, Parity and Previous LB with general
estimating equations to control for cluster level effects
cEstimate from a multivariable regression model adjusting for at least one polyhydramnios finding, DRC/Other, Age, Parity and Previous LB with general
estimating equations to control for cluster level effects
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This limitation prevented us from determining the
etiology of polyhydramnios or the effect these under-
lying pathologies might have had on outcomes.
Our study was not designed to investigate the causal
factors for polyhydramnios. Polyhydramnios results from
a disruption of the equilibrium between the production
and resorption of amniotic fluid. Imbalances could result
from increased production of fluid through fetal urin-
ation and production of fetal lung fluid or from impaired
reabsorption from impaired fetal swallowing and dimin-
ished intramembranous and intravascular absorption.
Although mild polyhydramnios is often idiopathic, re-
ported causes of moderate and severe polyhydramnios
include: fetal malformations and genetic anomalies
(8–45%), maternal diabetes mellitus (5–26%), multiple
pregnancies (8–10%), fetal anemia (1–11%), and other
causes, including viral infections, Bartter syndrome,
neuromuscular disorders and maternal hypercalcemia
[13]. Although our study could not determine the eti-
ology of polyhydramnios, we observed a trend toward
more amniotic fluid with larger birth weights. It is
unknown if this trend is caused by maternal diabetes
or another etiologic factor that was not tested in the
course of this study, and is not tested as part of rou-
tine antenatal care in the areas studied. Other factors,
including sociodemographic and ethnic factors might
contribute to polyhydramnios, but were not evaluated
in this study. Additional investigation is warranted to
determine the etiology of polyhydramnios in LMICs,
and to determine the differential exposures that led
to the higher incidence of polyhydramnios observed
in this study in the DRC.
By demonstrating a high incidence of polyhydram-
nios in the DRC, we identify a critical gap in know-
ledge about the etiology of polyhydramnios and the
site specific risk factors that contribute. Also, given
the high rate of polyhydramnios, and the association
with fetal malposition and obstructed labor, this rep-
resents an important publc health problem. In order
to prevent pregnancy complications that result from
antenatal conditions, like polyhydramnios, women
need appropriate antenatal care to identify these con-
ditions and appropriate referral for treatment to facil-
ities with the capability to treat those conditions,
including performing C-sections when warranted [14].
Despite the high incidence of polyhydramnios in the
DRC compared to other sites, few C-sections were
performed. In this study, the percentage of C-sections
performed in the DRC was 1.5% compared to 13% in
the other sites, which likely represents inadequate
resources to perform C-sections in the area. In areas
such as these, where resources for C-section are lim-
ited, direction of these resources to the highest risk
patients might improve perinatal health. Therefore,
the use of antenatal ultrasound to assist in the diag-
nosis of polyhydramnios may encourage appropriate
referrals of high risk patients to delivery facilities
capable of caring for these high risk patients.
Conclusions
This study identified the incidence of polyhydramnios in
LMICs, and confirmed its association with adverse preg-
nancy outcomes and neonatal mortality. We identified a
high incidence of polyhydramnios in the DRC compared
to other LMICs. These findings should be replicated, in
order to better understand the higher than expected in-
cidence of polyhydramnios in this area. If these findings
are replicated, the identification of polyhydramnios dur-
ing pregnancy could direct essential medical care to the
women and infants most at risk for adverse pregnancy
outcomes. In areas where resources for C-section are
limited, a system that identifies women with polyhy-
dramnios, and directs limited reources to these mothers,
might reduce neonatal mortality rates in these high risk
pregnancies. Identification of polyhydramnios during
pregnancy, and appropriate treatment or referral could
prevent subsequent adverse pregnancy outcomes and
neonatal death. Our findings have underscored the
importance of understanding the etiology of polyhy-
dramnios in this environment and a case-control trial is
underway to evaluate this finding.
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